Edwards Lifesciences posts posts Street-beating Q4, mixed-bag 2018 earnings

Edwards Lifesciences (NYSE:EW) today posted fourth quarter and full year 2018 earnings that topped earnings per share expectations on Wall Street, but missed on full-year sales consensus.